Microsoft Dynamics 365 CRM stands out as a comprehensive AI-powered platform designed to meet the evolving needs of ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

In its early access state, No Rest for the Wicked is already full of surprises. Mostly those are great, like how one moment I found myself marveling at its slow and precise combat (all but ...

Structure Therapeutics (GPCR) is stepping into the spotlight as it prepares to release topline data from its ACCESS trial of aleniglipron, an oral GLP 1 candidate for obesity, along with a same day ...

The World Economic Outlook (WEO) database contains selected macroeconomic data series from the statistical appendix of the World Economic Outlook report, which presents the IMF staff's analysis and ...

Chair in the History of Finance and Associate Pro-Vice-Chancellor Research, Prosperity and Resilience, Henley Business School, University of Reading Adrian R Bell receives funding from UKRI via AHRC.

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Check syllabus and exam pattern. Learn topics in General Knowledge, Reasoning, Mental Ability, and Computer Science for ...

Discover the top mobile app development tools for 2025, designed to accelerate app creation and improve user experience. From low-code solutions to comprehensive IDEs, find the right tools for your ...